financetom
Business
financetom
/
Business
/
Global Payments Dips Over 11% After Q1 Earnings - Read Why
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Global Payments Dips Over 11% After Q1 Earnings - Read Why
May 1, 2024 9:41 AM

Global Payments Inc. shares are trading lower after the company reported first-quarter financial results.

Global Payments ( GPN ) reported adjusted earnings per share of $2.59, beating the street view of $2.57. 

Quarterly adjusted revenue of $2.184 billion beat the street view of $2.176 billion. Adjusted net revenues increased 7% year over year.

Adjusted operating margin expanded 40 basis points to 43.5%.

Dividend: The company approved a dividend of $0.25 per share payable on June 28 to shareholders of record as of June 14.

Outlook: The company continues to expect FY24 adjusted net revenue of $9.17 billion-$9.30 billion versus the $9.24 estimate, reflecting growth of 6% to 7%.

Adjusted EPS to range from $11.54-$11.70 versus the $11.59 estimate, reflecting growth of 11% to 12% over 2023. 

Josh Whipple, Senior Executive Vice President and Chief Financial Officer, said, “While trends in the business remain stable, our outlook continues to reflect the potential for a slightly more tempered economic environment than we saw in 2023.”

Price Action: GPN shares are trading lower by 11.1% to $109.20 at last check Wednesday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Copyright 2023-2025 - www.financetom.com All Rights Reserved